SIMILAR PATTERNS OF AMINO ACIDS FOR 1OHR_A_1UNA201_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dkd GROEL

(Escherichia
coli)
PF00118
(Cpn60_TCP1)
5 LEU A 222
VAL A 276
ILE A 325
PRO A 279
ILE A 250
None
1.01A 1ohrB-1dkdA:
undetectable
1ohrB-1dkdA:
20.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.33A 1ohrB-1hvcA:
15.0
1ohrB-1hvcA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.58A 1ohrB-1hvcA:
15.0
1ohrB-1hvcA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.96A 1ohrB-1hvcA:
15.0
1ohrB-1hvcA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.78A 1ohrB-1hvcA:
15.0
1ohrB-1hvcA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1la1 GROEL

(Escherichia
coli)
PF00118
(Cpn60_TCP1)
5 LEU A 222
VAL A 276
ILE A 325
PRO A 279
ILE A 250
None
1.00A 1ohrB-1la1A:
undetectable
1ohrB-1la1A:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1orq POTASSIUM CHANNEL

(Aeropyrum
pernix)
PF00520
(Ion_trans)
6 LEU C 218
VAL C  39
GLY C 209
ILE C 168
VAL C  44
ILE C  40
None
1.49A 1ohrB-1orqC:
undetectable
1ohrB-1orqC:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1poi GLUTACONATE COENZYME
A-TRANSFERASE


(Acidaminococcus
fermentans)
PF01144
(CoA_trans)
6 VAL B  27
ILE B  21
GLY B  37
ILE B  36
VAL B  53
ILE B  51
None
1.07A 1ohrB-1poiB:
undetectable
1ohrB-1poiB:
15.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.62A 1ohrB-1sivA:
17.9
1ohrB-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1su7 CARBON MONOXIDE
DEHYDROGENASE 2


(Carboxydothermus
hydrogenoformans)
PF03063
(Prismane)
5 VAL A 270
ILE A 306
GLY A 292
ILE A 293
ILE A 269
None
0.98A 1ohrB-1su7A:
undetectable
1ohrB-1su7A:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2x ADP-SPECIFIC
PHOSPHOFRUCTOKINASE


(Pyrococcus
horikoshii)
PF04587
(ADP_PFK_GK)
5 VAL A 356
GLY A 341
ILE A 344
VAL A 306
ILE A 308
None
0.94A 1ohrB-1u2xA:
undetectable
1ohrB-1u2xA:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vkn N-ACETYL-GAMMA-GLUTA
MYL-PHOSPHATE
REDUCTASE


(Thermotoga
maritima)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A  70
VAL A 139
ILE A 120
VAL A  89
ILE A  91
None
0.86A 1ohrB-1vknA:
undetectable
1ohrB-1vknA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vzo RIBOSOMAL PROTEIN S6
KINASE ALPHA 5


(Homo sapiens)
PF00069
(Pkinase)
5 VAL A 331
ILE A 321
GLY A 159
ILE A 161
PRO A 334
None
1.00A 1ohrB-1vzoA:
undetectable
1ohrB-1vzoA:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wle SERYL-TRNA
SYNTHETASE


(Bos taurus)
PF00587
(tRNA-synt_2b)
6 LEU A 468
VAL A 458
ILE A 191
PRO A 461
VAL A 460
ILE A 473
None
1.33A 1ohrB-1wleA:
undetectable
1ohrB-1wleA:
11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.85A 1ohrB-1wsvA:
undetectable
1ohrB-1wsvA:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yxy PUTATIVE
N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE


(Streptococcus
pyogenes)
PF04131
(NanE)
5 LEU A 182
GLY A 153
ILE A 124
VAL A 189
ILE A 187
None
0.99A 1ohrB-1yxyA:
undetectable
1ohrB-1yxyA:
18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2avt DNA POLYMERASE III
BETA SUBUNIT


(Streptococcus
pyogenes)
PF00712
(DNA_pol3_beta)
PF02767
(DNA_pol3_beta_2)
PF02768
(DNA_pol3_beta_3)
5 LEU A 359
VAL A 264
ILE A 299
VAL A 346
ILE A 348
None
0.88A 1ohrB-2avtA:
undetectable
1ohrB-2avtA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bb0 IMIDAZOLONEPROPIONAS
E


(Bacillus
subtilis)
PF01979
(Amidohydro_1)
5 LEU A 374
VAL A  48
ILE A   5
ILE A  65
ILE A  47
None
1.01A 1ohrB-2bb0A:
undetectable
1ohrB-2bb0A:
13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cl2 PUTATIVE
LAMINARINASE


(Phanerochaete
chrysosporium)
no annotation 5 LEU A  52
VAL A  89
ILE A 119
ILE A 248
ILE A 291
None
0.85A 1ohrB-2cl2A:
undetectable
1ohrB-2cl2A:
16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cun PHOSPHOGLYCERATE
KINASE


(Pyrococcus
horikoshii)
PF00162
(PGK)
5 LEU A 316
ILE A 376
GLY A 357
VAL A 343
ILE A 347
None
0.93A 1ohrB-2cunA:
undetectable
1ohrB-2cunA:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cv6 SEED STORAGE PROTEIN

(Vigna radiata)
PF00190
(Cupin_1)
5 LEU A 296
ILE A 287
ILE A 284
VAL A 336
ILE A 294
None
1.00A 1ohrB-2cv6A:
undetectable
1ohrB-2cv6A:
15.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
VAL A  32
GLY A  54
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.90A 1ohrB-2fmbA:
15.0
1ohrB-2fmbA:
30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
None
LP1  A 201 (-2.3A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.56A 1ohrB-2fmbA:
15.0
1ohrB-2fmbA:
30.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hxr HTH-TYPE
TRANSCRIPTIONAL
REGULATOR CYNR


(Escherichia
coli)
PF03466
(LysR_substrate)
5 LEU A 267
VAL A  97
GLY A 107
VAL A 143
ILE A 145
None
0.91A 1ohrB-2hxrA:
undetectable
1ohrB-2hxrA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i6t UBIQUITIN-CONJUGATIN
G ENZYME E2-LIKE
ISOFORM A


(Homo sapiens)
PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C)
5 LEU A 210
VAL A 248
ILE A 401
VAL A 187
ILE A 185
None
1.00A 1ohrB-2i6tA:
undetectable
1ohrB-2i6tA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nr7 SECRETION ACTIVATOR
PROTEIN, PUTATIVE


(Porphyromonas
gingivalis)
PF05838
(Glyco_hydro_108)
PF09374
(PG_binding_3)
5 LEU A 134
GLY A 102
ILE A 103
VAL A  87
ILE A 138
None
0.80A 1ohrB-2nr7A:
undetectable
1ohrB-2nr7A:
23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pyx TRYPTOPHAN
HALOGENASE


(Shewanella
frigidimarina)
PF04820
(Trp_halogenase)
5 LEU A  42
VAL A 190
GLY A  18
ILE A 349
ILE A  44
None
0.96A 1ohrB-2pyxA:
undetectable
1ohrB-2pyxA:
10.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qdl CHEMOTAXIS SIGNAL
TRANSDUCTION PROTEIN


(Caldanaerobacter
subterraneus)
PF01584
(CheW)
5 LEU A  95
VAL A  34
ILE A  14
VAL A  86
ILE A  84
None
GOL  A 166 ( 4.5A)
None
None
None
0.95A 1ohrB-2qdlA:
undetectable
1ohrB-2qdlA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r77 PHOSPHATIDYLETHANOLA
MINE-BINDING
PROTEIN, PUTATIVE


(Plasmodium
falciparum)
PF01161
(PBP)
5 LEU A 131
VAL A  91
ILE A 191
VAL A 110
ILE A 107
None
0.94A 1ohrB-2r77A:
undetectable
1ohrB-2r77A:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r9q 2'-DEOXYCYTIDINE
5'-TRIPHOSPHATE
DEAMINASE


(Agrobacterium
fabrum)
PF06559
(DCD)
5 LEU A  87
VAL A 229
GLY A 118
VAL A 158
ILE A 156
None
1.00A 1ohrB-2r9qA:
undetectable
1ohrB-2r9qA:
14.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.53A 1ohrB-2rkfA:
20.0
1ohrB-2rkfA:
87.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.77A 1ohrB-2rkfA:
20.0
1ohrB-2rkfA:
87.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xwu IMPORTIN13

(Homo sapiens)
PF03810
(IBN_N)
PF08389
(Xpo1)
5 LEU B 610
ILE B 640
GLY B 642
VAL B 680
ILE B 614
None
0.82A 1ohrB-2xwuB:
undetectable
1ohrB-2xwuB:
8.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cp8 TRNA URIDINE
5-CARBOXYMETHYLAMINO
METHYL MODIFICATION
ENZYME GIDA


(Chlorobaculum
tepidum)
PF01134
(GIDA)
PF13932
(GIDA_assoc)
5 LEU A 116
ASP A 118
VAL A   7
GLY A 122
ILE A  30
None
0.95A 1ohrB-3cp8A:
undetectable
1ohrB-3cp8A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dzc UDP-N-ACETYLGLUCOSAM
INE 2-EPIMERASE


(Vibrio cholerae)
PF02350
(Epimerase_2)
5 LEU A  92
VAL A  34
ILE A  53
VAL A   4
ILE A   6
None
0.96A 1ohrB-3dzcA:
undetectable
1ohrB-3dzcA:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd0 PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
innocua)
PF06838
(Met_gamma_lyase)
5 LEU A 114
GLY A  95
ILE A  96
VAL A 118
ILE A 117
None
0.93A 1ohrB-3fd0A:
undetectable
1ohrB-3fd0A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gmi UPF0348 PROTEIN
MJ0951


(Methanocaldococcus
jannaschii)
PF05636
(HIGH_NTase1)
PF16581
(HIGH_NTase1_ass)
6 LEU A 312
ILE A 123
GLY A 125
PRO A 289
VAL A 292
ILE A 324
None
None
MLI  A 401 (-3.3A)
None
None
None
1.39A 1ohrB-3gmiA:
undetectable
1ohrB-3gmiA:
14.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 891
ILE A 885
ILE A1019
VAL A1006
ILE A1038
None
0.81A 1ohrB-3hngA:
undetectable
1ohrB-3hngA:
14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ht4 ALUMINUM RESISTANCE
PROTEIN


(Bacillus cereus)
PF06838
(Met_gamma_lyase)
5 LEU A 121
GLY A 102
ILE A 103
VAL A 125
ILE A 124
None
0.86A 1ohrB-3ht4A:
undetectable
1ohrB-3ht4A:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jtx AMINOTRANSFERASE

(Neisseria
meningitidis)
PF00155
(Aminotran_1_2)
5 LEU A 344
VAL A  32
ILE A 312
VAL A 352
ILE A 350
None
0.97A 1ohrB-3jtxA:
undetectable
1ohrB-3jtxA:
14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jzl PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE


(Listeria
monocytogenes)
PF06838
(Met_gamma_lyase)
5 LEU A 114
GLY A  95
ILE A  96
VAL A 118
ILE A 117
None
0.89A 1ohrB-3jzlA:
undetectable
1ohrB-3jzlA:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3krz NADH:FLAVIN
OXIDOREDUCTASE/NADH
OXIDASE


(Thermoanaerobacter
pseudethanolicus)
PF00724
(Oxidored_FMN)
5 LEU A 101
VAL A 215
ILE A 239
VAL A 160
ILE A 162
None
0.90A 1ohrB-3krzA:
undetectable
1ohrB-3krzA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lsc TRIAZINE HYDROLASE

(Paenarthrobacter
aurescens)
PF01979
(Amidohydro_1)
5 LEU A 383
VAL A  33
ILE A  48
VAL A  35
ILE A  32
None
1.01A 1ohrB-3lscA:
undetectable
1ohrB-3lscA:
12.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans)
PF05572
(Peptidase_M43)
5 LEU A 171
GLY A 211
ILE A  93
VAL A  69
ILE A 173
None
0.98A 1ohrB-3lunA:
undetectable
1ohrB-3lunA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgl SULFATE PERMEASE
FAMILY PROTEIN


(Vibrio cholerae)
PF01740
(STAS)
5 LEU A 475
VAL A 532
GLY A 522
VAL A 505
ILE A 507
None
0.88A 1ohrB-3mglA:
undetectable
1ohrB-3mglA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mwe ATP-CITRATE SYNTHASE

(Homo sapiens)
PF16114
(Citrate_bind)
5 LEU A 217
VAL A 121
ILE A 185
GLY A 187
ILE A 202
None
0.99A 1ohrB-3mweA:
undetectable
1ohrB-3mweA:
12.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
VAL A  82
ILE A  84
None
0.57A 1ohrB-3mwsA:
19.0
1ohrB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
PRO A  81
VAL A  82
ILE A  84
None
0.68A 1ohrB-3mwsA:
19.0
1ohrB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 VAL A  32
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.88A 1ohrB-3mwsA:
19.0
1ohrB-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nwg MICROCOMPARTMENTS
PROTEIN


(Desulfitobacterium
hafniense)
PF00936
(BMC)
5 LEU A  30
VAL A  52
ILE A  72
ILE A 104
ILE A  45
None
0.98A 1ohrB-3nwgA:
undetectable
1ohrB-3nwgA:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r5b TETRAHYDRODIPICOLINA
TE
N-SUCCINYLETRANSFERA
SE


(Pseudomonas
aeruginosa)
PF14602
(Hexapep_2)
PF14789
(THDPS_M)
PF14790
(THDPS_N)
5 LEU A 236
VAL A 278
ILE A 284
GLY A 269
ILE A 262
None
1.01A 1ohrB-3r5bA:
undetectable
1ohrB-3r5bA:
16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r9u THIOREDOXIN
REDUCTASE


(Campylobacter
jejuni)
PF07992
(Pyr_redox_2)
5 LEU A  14
VAL A 290
ILE A  46
GLY A  58
ILE A  59
None
FAD  A 501 (-4.0A)
FAD  A 501 (-4.3A)
None
None
0.90A 1ohrB-3r9uA:
undetectable
1ohrB-3r9uA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sb4 HYPOTHETICAL LEUCINE
RICH REPEAT PROTEIN


(Bacteroides
thetaiotaomicron)
PF13306
(LRR_5)
5 LEU A 159
VAL A 104
ILE A  76
ILE A 148
ILE A 135
None
1.01A 1ohrB-3sb4A:
undetectable
1ohrB-3sb4A:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
VAL A  39
GLY A  56
PRO A  89
None
3TL  A 126 (-2.4A)
None
3TL  A 126 (-3.4A)
3TL  A 126 (-4.0A)
0.71A 1ohrB-3slzA:
11.2
1ohrB-3slzA:
27.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.64A 1ohrB-3t3cA:
18.3
1ohrB-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
None
None
017  A 201 (-4.0A)
None
0.89A 1ohrB-3t3cA:
18.3
1ohrB-3t3cA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqv NICOTINATE-NUCLEOTID
E PYROPHOSPHORYLASE


(Francisella
tularensis)
PF01729
(QRPTase_C)
PF02749
(QRPTase_N)
5 LEU A 138
VAL A 247
ILE A 232
VAL A 269
ILE A 267
None
0.97A 1ohrB-3tqvA:
undetectable
1ohrB-3tqvA:
16.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
ILE A  50
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.7A)
0.56A 1ohrB-3ttpA:
18.7
1ohrB-3ttpA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.0A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.70A 1ohrB-3ttpA:
18.7
1ohrB-3ttpA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ILE A  47
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.60A 1ohrB-3u7sA:
19.0
1ohrB-3u7sA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ILE A  47
GLY A  49
PRO A  81
None
017  A 202 ( 2.5A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 202 (-4.0A)
0.59A 1ohrB-3u7sA:
19.0
1ohrB-3u7sA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v70 GTPASE IMAP FAMILY
MEMBER 1


(Homo sapiens)
PF04548
(AIG1)
5 LEU A 115
VAL A  81
GLY A 102
VAL A  33
ILE A  31
None
0.74A 1ohrB-3v70A:
undetectable
1ohrB-3v70A:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.96A 1ohrB-3vidA:
undetectable
1ohrB-3vidA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vmw PECTATE LYASE

(Bacillus sp.
N16-5)
PF00544
(Pec_lyase_C)
5 LEU A  99
ILE A  56
ILE A  84
VAL A  68
ILE A  97
None
1.00A 1ohrB-3vmwA:
undetectable
1ohrB-3vmwA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.85A 1ohrB-3wzdA:
undetectable
1ohrB-3wzdA:
14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a1o BIFUNCTIONAL PURINE
BIOSYNTHESIS PROTEIN
PURH


(Mycobacterium
tuberculosis)
PF01808
(AICARFT_IMPCHas)
PF02142
(MGS)
5 LEU A 352
GLY A 315
ILE A 281
VAL A 360
ILE A 358
None
0.91A 1ohrB-4a1oA:
undetectable
1ohrB-4a1oA:
10.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 VAL A 898
ILE A 892
ILE A1025
VAL A1012
ILE A1044
None
0.93A 1ohrB-4agdA:
undetectable
1ohrB-4agdA:
12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f4o HAPTOGLOBIN

(Sus scrofa)
PF00089
(Trypsin)
5 LEU C 138
VAL C 177
ILE C 158
ILE C 121
ILE C 191
None
0.99A 1ohrB-4f4oC:
undetectable
1ohrB-4f4oC:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hr3 PUTATIVE ACYL-COA
DEHYDROGENASE


(Mycobacteroides
abscessus)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
5 VAL A 242
ILE A 216
ILE A 189
VAL A 168
ILE A 170
None
1.01A 1ohrB-4hr3A:
undetectable
1ohrB-4hr3A:
13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mde METALLOPHOSPHOESTERA
SE


(Ruminiclostridium
thermocellum)
PF13671
(AAA_33)
5 VAL A 105
ILE A 141
GLY A 143
VAL A  12
ILE A  14
None
0.97A 1ohrB-4mdeA:
undetectable
1ohrB-4mdeA:
18.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
RIT  A 500 (-2.4A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.63A 1ohrB-4njvA:
19.8
1ohrB-4njvA:
87.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nky STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE


(Homo sapiens)
PF00067
(p450)
5 LEU A 396
VAL A  76
ILE A 381
ILE A  87
ILE A 394
None
0.98A 1ohrB-4nkyA:
undetectable
1ohrB-4nkyA:
11.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nu2 ANTIFREEZE PROTEIN

(Flavobacterium
frigoris)
PF11999
(DUF3494)
5 LEU A 178
VAL A 229
GLY A 239
ILE A 221
VAL A 198
None
0.93A 1ohrB-4nu2A:
undetectable
1ohrB-4nu2A:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nu3 ICE-BINDING PROTEIN

(Flavobacterium
frigoris)
PF11999
(DUF3494)
5 LEU A 158
VAL A 209
GLY A 219
ILE A 201
VAL A 178
None
0.94A 1ohrB-4nu3A:
undetectable
1ohrB-4nu3A:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqr CYP105AS1

(Amycolatopsis
orientalis)
PF00067
(p450)
5 LEU A 312
VAL A  50
ILE A  61
VAL A 315
ILE A 310
None
0.96A 1ohrB-4oqrA:
undetectable
1ohrB-4oqrA:
14.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oqs CYP105AS1

(Amycolatopsis
orientalis)
PF00067
(p450)
5 LEU A 312
VAL A  50
ILE A  61
VAL A 315
ILE A 310
None
0.97A 1ohrB-4oqsA:
undetectable
1ohrB-4oqsA:
13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pyr PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC TRANSPORTER


(Chromobacterium
violaceum)
PF04348
(LppC)
5 LEU A 166
VAL A  88
GLY A 107
ILE A 337
ILE A 146
None
0.87A 1ohrB-4pyrA:
undetectable
1ohrB-4pyrA:
12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q34 UNCHARACTERIZED
PROTEIN


(Parabacteroides
distasonis)
PF12697
(Abhydrolase_6)
5 LEU A 294
VAL A 258
ILE A 210
GLY A 200
VAL A 301
None
None
GOL  A 406 (-3.9A)
None
None
0.92A 1ohrB-4q34A:
undetectable
1ohrB-4q34A:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r5o QUINONPROTEIN
ALCOHOL
DEHYDROGENASE-LIKE
PROTEIN


(Bacteroides
thetaiotaomicron)
PF16819
(DUF5074)
PF16820
(PKD_3)
5 LEU A 330
VAL A 309
ILE A 251
VAL A 322
ILE A 324
None
0.72A 1ohrB-4r5oA:
undetectable
1ohrB-4r5oA:
12.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tv6 2-DEHYDRO-3-DEOXYGLU
CARATE ALDOLASE


(Staphylococcus
aureus)
PF03328
(HpcH_HpaI)
5 VAL A 172
ILE A 233
ILE A  43
PRO A  95
ILE A 147
None
None
None
OAA  A 301 (-4.8A)
None
1.00A 1ohrB-4tv6A:
undetectable
1ohrB-4tv6A:
16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xxp PUTATIVE
UNCHARACTERIZED
PROTEIN (RV0315
ORTHOLOG)


(Mycobacterium
avium)
PF00722
(Glyco_hydro_16)
5 LEU A 152
VAL A 177
GLY A 208
VAL A 162
ILE A 160
None
1.01A 1ohrB-4xxpA:
undetectable
1ohrB-4xxpA:
17.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 LEU A  30
ASP A  32
VAL A  39
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.62A 1ohrB-4ydfA:
13.4
1ohrB-4ydfA:
31.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
6 VAL A 221
ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
0.93A 1ohrB-4ywlA:
undetectable
1ohrB-4ywlA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zkt BOTULINUM NEUROTOXIN
TYPE E,
NONTOXIC-NONHEMAGGLU
TININ COMPONENT,
NTNH


(Clostridium
botulinum)
PF01742
(Peptidase_M27)
PF07953
(Toxin_R_bind_N)
PF08470
(NTNH_C)
5 LEU B1147
ASP B1146
VAL B1131
ILE B1098
VAL B1129
None
0.92A 1ohrB-4zktB:
undetectable
1ohrB-4zktB:
5.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw5 BRCA1/BRCA2-CONTAINI
NG COMPLEX SUBUNIT 3


(Camponotus
floridanus)
PF01398
(JAB)
5 LEU A  79
VAL A  89
GLY A  33
ILE A  51
ILE A  36
None
0.94A 1ohrB-5cw5A:
undetectable
1ohrB-5cw5A:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5epa SNOK

(Streptomyces
nogalater)
PF05721
(PhyH)
5 VAL A 201
ILE A  88
GLY A  90
VAL A  27
ILE A  29
None
0.74A 1ohrB-5epaA:
undetectable
1ohrB-5epaA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hee PUTATIVE
UNCHARACTERIZED
PROTEIN, TK2203
PROTEIN


(Thermococcus
kodakarensis)
PF02900
(LigB)
5 LEU A 136
VAL A 169
GLY A 232
VAL A  43
ILE A  45
None
0.97A 1ohrB-5heeA:
undetectable
1ohrB-5heeA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ihe DNA POLYMERASE II
SMALL SUBUNIT


(Pyrococcus
abyssi)
PF00149
(Metallophos)
5 LEU A 488
VAL A 199
GLY A 447
ILE A 401
ILE A 486
None
1.01A 1ohrB-5iheA:
undetectable
1ohrB-5iheA:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jpq ES6

(Chaetomium
thermophilum)
no annotation 5 LEU r 111
ILE r 101
GLY r 103
VAL r  36
ILE r  52
None
0.98A 1ohrB-5jpqr:
undetectable
1ohrB-5jpqr:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lcn UNCHARACTERIZED
PROTEIN


(Pyrococcus
furiosus)
PF12146
(Hydrolase_4)
5 LEU A 159
VAL A 214
ILE A 175
ILE A 228
ILE A 156
None
1.02A 1ohrB-5lcnA:
undetectable
1ohrB-5lcnA:
18.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
ILE A  50
ILE A  84
None
0.46A 1ohrB-5t2zA:
18.9
1ohrB-5t2zA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
VAL A  32
ILE A  47
GLY A  49
PRO A  81
ILE A  84
None
0.66A 1ohrB-5t2zA:
18.9
1ohrB-5t2zA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tc4 BIFUNCTIONAL
METHYLENETETRAHYDROF
OLATE
DEHYDROGENASE/CYCLOH
YDROLASE,
MITOCHONDRIAL


(Homo sapiens)
PF00763
(THF_DHG_CYH)
PF02882
(THF_DHG_CYH_C)
5 LEU A  45
VAL A 180
ILE A 251
ILE A 305
ILE A 183
None
1.01A 1ohrB-5tc4A:
undetectable
1ohrB-5tc4A:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5te1 ATP-CITRATE SYNTHASE

(Homo sapiens)
PF00549
(Ligase_CoA)
PF02629
(CoA_binding)
PF16114
(Citrate_bind)
5 LEU A 217
VAL A 121
ILE A 185
GLY A 187
ILE A 202
None
1.02A 1ohrB-5te1A:
undetectable
1ohrB-5te1A:
8.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vmt GLYCERALDEHYDE-3-PHO
SPHATE DEHYDROGENASE


(Neisseria
gonorrhoeae)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 LEU A  94
VAL A  32
ILE A  65
VAL A   5
ILE A   7
None
0.94A 1ohrB-5vmtA:
undetectable
1ohrB-5vmtA:
14.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w0s 60 KDA CHAPERONIN

(Escherichia
coli)
PF00118
(Cpn60_TCP1)
5 LEU A 222
VAL A 276
ILE A 325
PRO A 279
ILE A 250
None
0.93A 1ohrB-5w0sA:
undetectable
1ohrB-5w0sA:
10.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c49 ALCOHOL
DEHYDROGENASE


(Acinetobacter
baumannii)
no annotation 5 LEU A  81
VAL A  72
ILE A  68
VAL A  33
ILE A  71
None
1.01A 1ohrB-6c49A:
undetectable
1ohrB-6c49A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d6k POLYRIBONUCLEOTIDE
NUCLEOTIDYLTRANSFERA
SE


(Acinetobacter
baumannii)
no annotation 5 LEU A  20
VAL A  41
ILE A 150
VAL A  32
ILE A  34
None
1.02A 1ohrB-6d6kA:
undetectable
1ohrB-6d6kA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6day DIHYDROPTEROATE
SYNTHASE


(Xanthomonas
albilineans)
no annotation 5 LEU A 220
VAL A 122
GLY A  63
ILE A  62
VAL A 142
None
0.95A 1ohrB-6dayA:
undetectable
1ohrB-6dayA:
18.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
None
None
0.93A 1ohrB-6upjA:
17.3
1ohrB-6upjA:
48.48